LEXICON PHARMACEUTICALS INC (LXRX) Stock Analyst Ratings
USA - NASDAQ:LXRX - US5288723027 - Common Stock
1.49 USD
+0.05 (+3.47%)
1.5 USD
+0.01 (+0.67%)
ChartMill assigns a Buy % Consensus number of 80% to LXRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.81. This target is 88.26% above the current price.
LXRX was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about LXRX.
In the previous month the buy percentage consensus was at a similar level.
LXRX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-07 | Citigroup | Maintains | Buy -> Buy |
| 2025-06-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-07 | Needham | Reiterate | Hold -> Hold |
| 2025-03-07 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-04 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-03-03 | Needham | Reiterate | Hold -> Hold |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-29 | Needham | Reiterate | Hold -> Hold |
| 2025-01-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-23 | Needham | Reiterate | Hold -> Hold |
| 2024-11-25 | Needham | Reiterate | Hold |
| 2024-11-22 | Needham | Reiterate | Hold |
| 2024-11-13 | Needham | Reiterate | Hold |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-01 | Needham | Reiterate | Hold |
| 2024-11-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-30 | Needham | Reiterate | Hold |
| 2024-10-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
LEXICON PHARMACEUTICALS INC / LXRX FAQ
Can you provide the average price target for LEXICON PHARMACEUTICALS INC stock?
11 analysts have analysed LXRX and the average price target is 2.81 USD. This implies a price increase of 88.26% is expected in the next year compared to the current price of 1.49.
How do analysts rate LEXICON PHARMACEUTICALS INC (LXRX)?
The consensus rating for LEXICON PHARMACEUTICALS INC (LXRX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for LXRX stock?
The number of analysts covering LEXICON PHARMACEUTICALS INC (LXRX) is 11.